10x Genomics, Inc. (TXG): Operating Cash Flow
$136.05M
Year ended 2025-12-31
$127.08M
Trailing 12 months to 2026-06-30
| Period ended | Operating Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $136.05M | n/m | 2026-02-13, From 2025-01-01 |
| 2024-12-31 | $6.66M | n/m | 2026-02-13, From 2024-01-01 |
| 2023-12-31 | -$15.20M | n/m | 2026-02-13, From 2023-01-01 |
| 2022-12-31 | -$33.61M | n/m | 2025-02-13, From 2022-01-01 |
| 2021-12-31 | -$21.37M | n/m | 2024-02-15, From 2021-01-01 |
| 2020-12-31 | -$217.90M | n/m | 2023-02-16, From 2020-01-01 |
| 2019-12-31 | $34.63M | n/m | 2022-02-18, From 2019-01-01 |
| 2018-12-31 | -$76.41M | n/m | 2021-02-26, From 2018-01-01 |
| 2017-12-31 | -$10.70M | n/a | 2020-02-27, From 2017-01-01 |
Operating Cash Flow at similar companies
| Company | Year ended | Operating Cash Flow | Change YoY |
|---|---|---|---|
| 10x Genomics, Inc. (TXG) | 2025-12-31 | $136.05M | n/m |
| Cytek Biosciences, Inc. (CTKB) | 2025-12-31 | -$4.69M | n/m |
| Pacific Biosciences of California, Inc. (PACB) | 2025-12-31 | -$111.21M | n/m |
| Bio-Rad Laboratories, Inc. (BIO) | 2025-12-31 | $532.20M | +16.9% |
| Revvity, Inc. (RVTY) | 2025-12-28 | $582.93M | -7.2% |
| Quanterix Corp (QTRX) | 2025-12-31 | -$77.24M | n/m |
| Waters Corp (WAT) | 2025-12-31 | $652.55M | -14.4% |
| Bruker Corp (BRKR) | 2025-12-31 | $134.10M | -46.6% |
| Mettler Toledo International Inc (MTD) | 2025-12-31 | $955.77M | -1.3% |
Compare TXG, CTKB, PACB, BIO side by side · Screen every company in Laboratory Analytical Instruments ↗